The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium

J Clin Invest. 1995 Feb;95(2):456-63. doi: 10.1172/JCI117685.

Abstract

To understand the accumulation of plasma cells within RA synovium, the ability of rheumatoid synoviocytes to support the differentiation of B cells into plasma cells was explored. Tonsillar B lymphocytes cultured over confluent monolayers of synoviocytes, secreted threefold more Igs (mainly IgM) than B cells cultured directly on plastic well. More importantly, synoviocytes enhanced by 14-fold the production of Igs (mainly IgG) by B cells costimulated with Staphylococcus aureus Cowan (SAC) particles. IL-10 and, in a lower extent, IL-2 increased Ig secretion in cocultures, and their combination was synergistic. In the presence of SAC, IL-2, and IL-10, synoviocytes increased by 13-884-fold the production of IgG, which reached 0.19 ng/cell per day. RA as well as normal synoviocytes were more potent than other adherent cell lines to support terminal B cell differentiation. Synoviocyte activity involved both a support of B cell survival, and an induction of the terminal differentiation of B cells into mature plasma cells with typical morphology, high levels of intracytoplasmic Igs, and CD20- CD38high surface expression. The present observation should permit the identification of molecules involved in the maturation of B cells into plasma cells, and in their accumulation in rheumatoid synovium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • Antibody Formation
  • Antigens, CD / analysis
  • Antigens, CD / biosynthesis
  • Antigens, CD20
  • Antigens, Differentiation, B-Lymphocyte / biosynthesis
  • Arthritis, Rheumatoid / immunology*
  • Arthritis, Rheumatoid / pathology
  • B-Lymphocytes / cytology
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology*
  • Cell Communication / immunology
  • Cell Differentiation
  • Cell Line
  • Cells, Cultured
  • Cytokines / pharmacology*
  • Drug Synergism
  • Flow Cytometry
  • Humans
  • Immunoenzyme Techniques
  • Immunoglobulin A / biosynthesis
  • Immunoglobulin G / biosynthesis
  • Immunoglobulin M / biosynthesis
  • Interleukin-10 / pharmacology
  • Interleukin-2 / pharmacology
  • Kinetics
  • Lymphocyte Activation
  • Plasma Cells / immunology*
  • Plasma Cells / pathology
  • Recombinant Proteins / pharmacology
  • Synovial Membrane / drug effects
  • Synovial Membrane / immunology*
  • Synovial Membrane / pathology
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, CD20
  • Antigens, Differentiation, B-Lymphocyte
  • Cytokines
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin M
  • Interleukin-2
  • Recombinant Proteins
  • Interleukin-10